Efficacy and Safety of IBI308 and Paclitaxel/Albumin Paclitaxel for SCLC Patients Who Failed Etoposide Chemotherapy

NCT04056949 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Extensive-Stage Small Cell Lung Cancer

Interventions

DRUG: Paclitaxel/Albumin-Bound Paclitaxel
DRUG: IBI308

Sponsor

Junling Li